REDUCTION OF [H-3] 6-NITROQUIPAZINE-LABELED 5-HYDROXYTRYPTAMINE UPTAKE SITES IN RAT-BRAIN BY 3,4-METHYLENEDIOXYMETHAMPHETAMINE

被引：22

作者：

HASHIMOTO, K

GOROMARU, T

机构：

[1] Department of Radiopharmaceutical Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences, University of Fukuyama, Fukuyama, 792-02

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1990年 / 4卷 / 06期

关键词：

3,4-METHYLENEDIOXYMETHAMPHETAMINE; 5-HYDROXYTRYPTAMINE UPTAKE SITES; H-3]6-NITROQUIPAZINE BINDING; RAT BRAIN;

D O I：

10.1111/j.1472-8206.1990.tb00043.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy) is a known neurotoxin to 5-hydroxytryptamine (5-HT; serotonin) nerve terminals. It has recently been demonstrated that [3H]6-nitroquipazine is a new radioligand for studying the 5-HT transport system in brain. Therefore, we examined the effects of repeated systemic administration (10 mg/kg ip, twice daily for 3 d) of MDMA on [3H]6-nitroquipazine-labelled 5-HT uptake sites in rat brain. Marked reductions in the concentrations of 5-HT and its major metabolite 5-hydroxyindoleacetic acid (5-HIAA) were observed in the cerebral cortex 1 week after the last injection of MDMA. In addition, the density of [3H]6-nitroquipazine-labelled 5-HT uptake sites was significantly decreased by MDMA. Furthermore, the reduction of 5-HT and 5-HIAA content and the density of [3H]6-nitroquipazine-labelled 5-HT uptake sites by MDMA were significantly prevented by co-administration of 6-nitroquipazine (5 mg/kg), a very potent and selective 5-HT uptake inhibitor. The present results indicate that the 5-HT uptake carrier plays an important role in the neurotoxic action of MDMA.

引用

页码：635 / 641

页数：7

共 18 条

[1] MDMA-INDUCED NEUROTOXICITY - PARAMETERS OF DEGENERATION AND RECOVERY OF BRAIN-SEROTONIN NEURONS [J].

BATTAGLIA, G ;

YEH, SY ;

DESOUZA, EB .

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1988, 29 (02) :269-274

[2]

BATTAGLIA G, 1987, J PHARMACOL EXP THER, V242, P911

[3] CENTRALLY ACTIVE N-SUBSTITUTED ANALOGS OF 3,4-METHYLENEDIOXYPHENYLISOPROPYLAMINE (3,4-METHYLENEDIOXYAMPHETAMINE) [J].

BRAUN, U ;

SHULGIN, AT ;

BRAUN, G .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (02) :192-195

[4] EFFECTS OF DU-24565 (6-NITROQUIPAZINE) ON SEROTONINERGIC AND NORADRENERGIC NEURONS OF THE RAT-BRAIN AND COMPARISON WITH THE EFFECTS OF QUIPAZINE [J].

CLASSEN, K ;

GOTHERT, M ;

SCHLICKER, E .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1984, 326 (03) :198-202

[5]

COMMINS DL, 1987, J PHARMACOL EXP THER, V241, P338

[6]

HASHIMOTO K, 1990, Radioisotopes, V39, P168

[7] HIGH-AFFINITY [H-3] 6-NITROQUIPAZINE BINDING-SITES IN RAT-BRAIN [J].

HASHIMOTO, K ;

GOROMARU, T .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 180 (2-3) :273-281

[8]

HASHIMOTO K, 1990, 3RD HIR INT S NEUR R, P106

[9] 5-HYDROXYTRYPTAMINE UPTAKE BLOCKERS ATTENUATE THE 5-HYDROXYTRYPTAMINE-RELEASING EFFECT OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND RELATED AGENTS [J].

HEKMATPANAH, CR ;

PEROUTKA, SJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 177 (1-2) :95-98

[10]

LOWRY OH, 1951, J BIOL CHEM, V193, P265

← 1 2 →